Lonafarnib may enhance the AUC and peak focus of CYP2C19 substrates. If coadministration unavoidable, watch for adverse reactions and lessen the CYP2C19 substrate dose in accordance with its approved product labeling.fentanyl iontophoretic transdermal system and diazepam both of those enhance sedation. Stay clear of or Use Alternate Drug. Limit use